Biocon’s net profits during January-March 2015 surged by 78% at Rs.201.54 crore of which the company got Rs.105 crore by selling some of its stakes in Syngene.
Biopharmaceutical Company Publishes Data on Novel IL-1 Inhibitor Protein for Topical Treatment of Dry Eye Disease
Preclinical data showing beneficial effects of EBI-005 was published by Eleven Biotherapeutics.
Preclinical data showing beneficial effects of EBI-005 was published by Eleven Biotherapeutics.
In a statement, chief managing director Kiran Mazumdar-Shaw said: "As we move into the fiscal year 2016, we are clearly seeing our biosimilar strategy playing out with greater clarity, credibility and traction visible across our portfolio of biologics as they advance in clinical development. We continue to make investments in Research and Development as a strong future value driver."
Source-Medindia
Japanese Pharmaceutical Company Starts Down's Therapy Test
A pharmaceutical company in Japan said it will begin therapeutic testing of a drug it hopes will slow the decline in quality of life for some people with Down's syndrome.
A pharmaceutical company in Japan said it will begin therapeutic testing of a drug it hopes will slow the decline in quality of life for some people with Down's syndrome.
Pharmaceutical Company Approved
Ipca Laboratories, one of the leading manufacturers and exporters of active pharmaceutical ingredients in India, has been approved by the UK health regulator for good manufacturing practices.
Ipca Laboratories, one of the leading manufacturers and exporters of active pharmaceutical ingredients in India, has been approved by the UK health regulator for good manufacturing practices.
Employment Furnished by Pharmaceutical Company for Kashmiri Youth
The pharmaceutical company set up in Jammu and Kashmir is godsend for educated youth in the valley, where they get to work and enhance their technical skills at the same time.
The pharmaceutical company set up in Jammu and Kashmir is godsend for educated youth in the valley, where they get to work and enhance their technical skills at the same time.
